These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 2680953)
21. Malignant and benign ovarian neoplasms among atomic bomb survivors, Hiroshima and Nagasaki, 1950-80. Tokuoka S; Kawai K; Shimizu Y; Inai K; Ohe K; Fujikura T; Kato H J Natl Cancer Inst; 1987 Jul; 79(1):47-57. PubMed ID: 3474449 [TBL] [Abstract][Full Text] [Related]
22. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 2. Cancer mortality based on the recently revised doses (DS86). Shimizu Y; Kato H; Schull WJ Radiat Res; 1990 Feb; 121(2):120-41. PubMed ID: 2305030 [TBL] [Abstract][Full Text] [Related]
23. Leukaemia following childhood radiation exposure in the Japanese atomic bomb survivors and in medically exposed groups. Little MP Radiat Prot Dosimetry; 2008; 132(2):156-65. PubMed ID: 18936088 [TBL] [Abstract][Full Text] [Related]
24. Comparison of the risks of cancer incidence and mortality following radiation therapy for benign and malignant disease with the cancer risks observed in the Japanese A-bomb survivors. Little MP Int J Radiat Biol; 2001 Apr; 77(4):431-64. PubMed ID: 11304437 [TBL] [Abstract][Full Text] [Related]
25. Analysis of the incidence of solid cancer among atomic bomb survivors using a two-stage model of carcinogenesis. Kai M; Luebeck EG; Moolgavkar SH Radiat Res; 1997 Oct; 148(4):348-58. PubMed ID: 9339951 [TBL] [Abstract][Full Text] [Related]
26. Breast cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with breast cancer mortality in the atomic bomb survivors study. Howe GR; McLaughlin J Radiat Res; 1996 Jun; 145(6):694-707. PubMed ID: 8643829 [TBL] [Abstract][Full Text] [Related]
27. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 1. Comparison of risk coefficients for site-specific cancer mortality based on the DS86 and T65DR shielded kerma and organ doses. Shimizu Y; Kato H; Schull WJ; Preston DL; Fujita S; Pierce DA Radiat Res; 1989 Jun; 118(3):502-24. PubMed ID: 2727272 [TBL] [Abstract][Full Text] [Related]
28. Timing of menarche and first birth in relation to risk of breast cancer in A-bomb survivors. McDougall JA; Sakata R; Sugiyama H; Grant E; Davis S; Nishi N; Soda M; Shimizu Y; Tatsukawa Y; Kasagi F; Suyama A; Ross P; Kopecky KJ; Li CI Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1746-54. PubMed ID: 20570914 [TBL] [Abstract][Full Text] [Related]
29. Somatic cell mutations at the glycophorin A locus in erythrocytes of atomic bomb survivors: implications for radiation carcinogenesis. Kyoizumi S; Akiyama M; Cologne JB; Tanabe K; Nakamura N; Awa AA; Hirai Y; Kusunoki Y; Umeki S Radiat Res; 1996 Jul; 146(1):43-52. PubMed ID: 8677297 [TBL] [Abstract][Full Text] [Related]
30. Cancer incidence in atomic bomb survivors. Part I: Use of the tumor registries in Hiroshima and Nagasaki for incidence studies. Mabuchi K; Soda M; Ron E; Tokunaga M; Ochikubo S; Sugimoto S; Ikeda T; Terasaki M; Preston DL; Thompson DE Radiat Res; 1994 Feb; 137(2 Suppl):S1-16. PubMed ID: 8127951 [TBL] [Abstract][Full Text] [Related]
31. [Trends in the incidence of uterine cancer in Nagasaki city, with special reference to previous atomic bomb exposure, 1973-1982]. Kajiwara Y; Ikeda T; Shimokawa I; Iwasaki K; Matsuo T; Mine M; Soda M Gan No Rinsho; 1990 Mar; 36(4):488-94. PubMed ID: 2319692 [TBL] [Abstract][Full Text] [Related]
32. Studies of the mortality of A-bomb survivors, report 7. Part III. incidence of cancer in 1959-1978, based on the tumor registry, Nagasaki. Wakabayashi T; Kato H; Ikeda T; Schull WJ Radiat Res; 1983 Jan; 93(1):112-46. PubMed ID: 6823504 [TBL] [Abstract][Full Text] [Related]
34. Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1980. Tokunaga M; Land CE; Yamamoto T; Asano M; Tokuoka S; Ezaki H; Nishimori I Radiat Res; 1987 Nov; 112(2):243-72. PubMed ID: 3685255 [TBL] [Abstract][Full Text] [Related]
36. Relationship of five anthropometric measurements at age 18 to radiation dose among atomic bomb survivors exposed in utero. Nakashima E Radiat Res; 1994 Apr; 138(1):121-6. PubMed ID: 8146291 [TBL] [Abstract][Full Text] [Related]
37. Understanding estimation of time and age effect-modification of radiation-induced cancer risks among atomic-bomb survivors. Lagarde F Health Phys; 2006 Dec; 91(6):608-18. PubMed ID: 17099404 [TBL] [Abstract][Full Text] [Related]
38. Multiple myeloma among atomic bomb survivors in Hiroshima and Nagasaki, 1950-76: relationship to radiation dose absorbed by marrow. Ichimaru M; Ishimaru T; Mikami M; Matsunaga M J Natl Cancer Inst; 1982 Aug; 69(2):323-8. PubMed ID: 6955540 [TBL] [Abstract][Full Text] [Related]
39. Profiles of non-cancer diseases in atomic bomb survivors. Kodama K; Fujiwara S; Yamada M; Kasagi F; Shimizu Y; Shigematsu I World Health Stat Q; 1996; 49(1):7-16. PubMed ID: 8896251 [TBL] [Abstract][Full Text] [Related]
40. Survival analyses of atomic bomb survivors in Hiroshima Prefecture, Japan, 1968-1982--cancer mortality risk among early entrants. Matsuura M; Hayakawa N; Shimokata H Hiroshima J Med Sci; 1995 Jun; 44(2):29-38. PubMed ID: 7591838 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]